Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Remifentanil in Extracorporeal Shock Wave Lithotripsy (ESWL)

This study has been completed.
Information provided by (Responsible Party):
Francesco Cannata, University of Roma La Sapienza Identifier:
First received: October 6, 2011
Last updated: October 12, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)